Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Ji Eun Park

Interventional Cardiology Tucson, AZ Medical Doctor

NPI 1417344417 CMS profile 11470734

3601 S 6Th Ave, Tucson, AZ 85723

Open in the dashboard

General payments

$15,251

163 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ji Eun Park of Tucson, AZ is reported in the CMS Open Payments database as having received $15,251 across 163 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,934 55
2024 General $6,289 59
2023 General $5,011 48
2022 General $16 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ji Eun Park
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Ji Eun Park were reported at $3,934. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Ji Eun Park Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $0 $473 $161–$1,480 $114
2021 $0 $677 $233–$1,827 $132
2022 $16 $978 $333–$2,724 $149
2023 $5,011 $1,136 $382–$2,986 $160
2024 $6,289 $1,181 $395–$3,326 $164
2025 $3,934 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $5,228 61 payments
  2. Abbott Laboratories $2,977 25 payments
  3. Edwards Lifesciences Corporation $2,227 27 payments
  4. Siemens Medical Solutions USA, Inc. $2,057 9 payments
  5. Abiomed $1,557 13 payments
  6. Boston Scientific Corporation $1,182 26 payments
  7. AstraZeneca Pharmaceuticals LP $16 1 payment
  8. Penumbra, Inc. $7 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $10,408 57 payments
  2. Food and Beverage $4,842 105 payments
  3. Education $1 1 payment
Products named General payments · program years 2022–2025
  1. COREVALVE EVOLUT R $4,882 50 payments
  2. OPTIS $2,452 15 payments
  3. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $1,191 20 payments
  4. SAPIEN 3 Ultra RESILIA $307 5 payments
  5. General - Stents $201 8 payments
  6. AMPLATZER AMULET $173 3 payments
  7. COROFLOW $142 1 payment
  8. WATCHMAN FLX $126 6 payments
  9. ONYX FRONTIER $101 1 payment
  10. DRAGONFLY OPSTAR $95 1 payment
  11. Other $251 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

163 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record